Despite long-term investment, influenza continues to be a significant worldwide problem.
The cornerstone of protection remains vaccination, and approved vaccines seek to elicit a …

Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led
to poorly defined viral prevalence rates in the United States and elsewhere. To address this, …

Influenza virus hemagglutinin (HA) surface glycoprotein is currently the primary target of
licensed influenza vaccines. Recently, broadly reactive antibodies that target the stalk region of …

Background In animal models, immunity to mosquito salivary proteins protects animals
against mosquito-borne disease. These findings provide a rationale to vaccinate against …

The conserved region of influenza hemagglutinin (HA) stalk (or stem) has gained attention
as a potent target for universal influenza vaccines 1 , 2 , 3 , 4 – 5 . Although the HA stalk …

Background The development of vaccines and therapeutics has relied on healthy volunteer
influenza challenge studies. A validated human infection model with wild-type A(H1N1)…

Background Identification of correlates of protection against human influenza A virus infection
is important in development of broadly protective (“universal”) influenza vaccines. Certain …

The continued explosive spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
despite aggressive public health measures has triggered an unprecedented …

The balance between pro- and antiinflammatory cytokines may be important in malaria
presentation and outcome. Malaria tends to be more severe in children than in adults, …

Background Preclinical animal studies and retrospective human studies suggest that adult
females have worse outcomes from influenza than males. Prospective studies in humans are …